Literature DB >> 12175558

Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT).

Kei Kitamura1, Hiroki Shirato, Shinichi Shimizu, Nobuo Shinohara, Toru Harabayashi, Tadashi Shimizu, Yoshihisa Kodama, Hideho Endo, Rikiya Onimaru, Seiko Nishioka, Hidefumi Aoyama, Kazuhiko Tsuchiya, Kazuo Miyasaka.   

Abstract

BACKGROUND AND
PURPOSE: We have developed a linear accelerator synchronized with a fluoroscopic real-time tumor-tracking system to reduce errors due to setup and organ motion. In the real-time tumor-tracking radiation therapy (RTRT) system, the accuracy of tumor tracking depends on the registration of the marker's coordinates. The registration accuracy and possible migration of the internal fiducial gold marker implanted into prostate and liver was investigated.
MATERIALS AND METHODS: Internal fiducial gold markers were implanted in 14 patients with prostate cancer and four patients with liver tumors. Computed tomography (CT) was carried out as a part of treatment planning in the 18 patients. A total of 72 follow-up CT scans were taken. We calculated the relative relationship between the coordinates of the center of mass (CM) of the organs and those of the marker. The discrepancy in the CM coordinates during a follow-up CT compared to those recorded during the planning CT was used to study possible marker migration.
RESULTS: The standard deviation (SD) of interobserver variations in the CM coordinates was within 2.0 and 0.4 mm for the organ and the marker, respectively, in seven observers. Assuming that organs do not shrink, grow, or rotate, the maximum SD of migration error in each direction was estimated to be less than 2.5 and 2.0 mm for liver and prostate, respectively. There was no correlation between the marker position and the time after implantation.
CONCLUSION: The degree of possible migration of the internal fiducial marker was within the limits of accuracy of the CT measurement. Most of the marker movement can be attributed to the measurement uncertainty, which also influences registration in actual treatment planning. Thus, even with the gold marker and RTRT system, a planning target volume margin should be used to account for registration uncertainty.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175558     DOI: 10.1016/s0167-8140(02)00017-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  27 in total

Review 1.  Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Authors:  Alan Pollack; Alex Hanlon; Eric M Horwitz; Steven Feigenberg; Robert G Uzzo; Robert A Price
Journal:  World J Urol       Date:  2003-09-05       Impact factor: 4.226

Review 2.  Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy.

Authors:  Hiroki Shirato; Shinichi Shimizu; Kei Kitamura; Rikiya Onimaru
Journal:  Int J Clin Oncol       Date:  2007-02-25       Impact factor: 3.402

3.  Technical note: Correlation of respiratory motion between external patient surface and internal anatomical landmarks.

Authors:  Hadi Fayad; Tinsu Pan; Jean François Clement; Dimitris Visvikis
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

4.  A novel approach for establishing benchmark CBCT/CT deformable image registrations in prostate cancer radiotherapy.

Authors:  Jinkoo Kim; Sanath Kumar; Chang Liu; Hualiang Zhong; Deepak Pradhan; Mira Shah; Richard Cattaneo; Raphael Yechieli; Jared R Robbins; Mohamed A Elshaikh; Indrin J Chetty
Journal:  Phys Med Biol       Date:  2013-10-31       Impact factor: 3.609

5.  Automatic tracking of arbitrarily shaped implanted markers in kilovoltage projection images: a feasibility study.

Authors:  Rajesh Regmi; D Michael Lovelock; Margie Hunt; Pengpeng Zhang; Hai Pham; Jianping Xiong; Ellen D Yorke; Karyn A Goodman; Andreas Rimner; Hassan Mostafavi; Gig S Mageras
Journal:  Med Phys       Date:  2014-07       Impact factor: 4.071

6.  A deformable model for tracking tumors across consecutive imaging studies.

Authors:  Gabriela Niculescu; John L Nosher; M D Benjamin Schneider; David J Foran
Journal:  Int J Comput Assist Radiol Surg       Date:  2009-06       Impact factor: 2.924

7.  Robust fluoroscopic tracking of fiducial markers: exploiting the spatial constraints.

Authors:  Rui Li; Gregory Sharp
Journal:  Phys Med Biol       Date:  2013-02-26       Impact factor: 3.609

8.  Analysis of fiducial markers used for on-line verification in the external-beam radiotherapy of patients with cranial tumours.

Authors:  R Ma Cañón; I Azinovic; M Lobato; J Navarro; J Rebollo
Journal:  Clin Transl Oncol       Date:  2007-08       Impact factor: 3.405

9.  A new scheme for real-time high-contrast imaging in lung cancer radiotherapy: a proof-of-concept study.

Authors:  Hao Yan; Zhen Tian; Yiping Shao; Steve B Jiang; Xun Jia
Journal:  Phys Med Biol       Date:  2016-03-04       Impact factor: 3.609

10.  Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report.

Authors:  Hooman Hennessey; David Valenti; Tatiana Cabrera; Valerie Panet-Raymond; David Roberge
Journal:  J Med Case Rep       Date:  2009-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.